PLSH on OTC
PANACEA LIFE SCIENCES HOLDINGS, INC.
American medicinal chemicals and botanical products company. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with Target Group Inc., HEALTHY EXTRACTS INC. or TFA Therapeutics, Inc., or pick any stock.
- TickerPLSH on OTC1
- IndustryMedicinal Chemicals & Botanical Products1
- HeadquartersGreenwood Village, Colorado1
- Incorporated inNV2
- Business address5910 South University Blvd, C18-193, Greenwood Village, Co 801212
- Filer category, Emerging growth company2
See how the biggest companies compare on our leaderboards
October 2021, Panacea Life Sciences’ investment in the Cannabinoid Lab at Colorado State University (“CSU”) was realized.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
Where the money goes
Where each dollar of revenue went, fiscal 2023
- Cost of revenue45¢$1.3M
- Interest55¢$1.6M
Out of $2.4M in revenue.4 The company lost money this year.
Financial statements
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenue | $05 | $06 | $345.7K7 | $9.0M8 | $2.1M9 | $1.6M4 | $2.4M4 |
| Cost of revenue | $06 | $1.9M7 | $7.0M8 | $1.5M9 | $1.2M4 | $1.3M4 | |
| Gross profit | $06 | -$1.7M7 | $2.0M8 | $540.6K9 | $396.5K4 | $1.1M4 | |
| Research and development | $356.1K5 | $300.0K6 | $22.1K7 | $07 | |||
| Operating expenses | $6.5M9 | $6.0M4 | $6.7M4 | ||||
| Operating income | -$3.1M5 | -$2.4M6 | -$10.7M7 | -$5.3M8 | -$5.9M9 | -$5.7M4 | -$5.5M4 |
| Interest | $68.6K5 | $464.5K6 | $479.1K7 | $1.5M8 | $1.1M9 | $2.0M4 | $1.6M4 |
| Income before tax | -$4.8M9 | -$9.1M4 | -$8.0M4 | ||||
| Income tax | $05 | $05 | |||||
| Net income | -$3.9M5 | -$4.3M6 | -$10.0M7 | -$5.2M8 | -$4.8M9 | -$9.1M4 | -$8.0M4 |
| Earnings per share | -$0.289 | -$0.624 | -$0.484 | ||||
| Earnings per share (diluted) | -$0.624 | -$0.484 | |||||
| Shares (weighted, basic) | 16.9M shares9 | 14.9M shares4 | 16.6M shares4 | ||||
| Shares (weighted, diluted) | 14.9M shares4 | 16.6M shares4 |
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Cash | $161.2K5 | $2.0K6 | $18.4K7 | $84.4K8 | $19.8K9 | $7.0K4 | $100.9K4 |
| Receivables | $244.5K9 | $206.1K4 | $264.0K4 | ||||
| Inventory | $4.3M9 | $4.4M4 | $4.0M4 | ||||
| Current assets | $172.7K5 | $14.3K6 | $2.4M7 | $11.5M8 | $9.1M9 | $6.4M4 | $4.7M4 |
| Property, plant and equipment | $8.8M9 | $7.7M4 | $6.4M4 | ||||
| Goodwill | $2.2M9 | $2.2M4 | $3.0M4 | ||||
| Intangible assets | $61.4K9 | $2.2M4 | $3.0M4 | ||||
| Total assets | $172.7K5 | $14.3K6 | $8.0M7 | $31.4M8 | $23.8M9 | $19.5M4 | $18.0M4 |
| Current liabilities | $2.4M5 | $3.3M6 | $3.8M7 | $18.3M8 | $10.1M9 | $15.1M4 | $19.4M4 |
| Long-term debt | $57.8K5 | $591.8K6 | $185.9K6 | $335.5K7 | |||
| Total liabilities | $2.4M5 | $3.4M6 | $4.1M7 | $24.7M8 | $16.7M9 | $21.6M4 | $26.3M4 |
| Retained earnings | -$16.8M9 | -$25.9M4 | -$33.9M4 | ||||
| Shareholders’ equity | -$2.2M5 | -$3.4M6 | $11.9M8 | $6.7M8 | $7.1M9 | -$2.1M4 | -$8.3M4 |
| Shares outstanding | 4.4M shares5 | 6.2M shares6 | 43.8M shares7 | 16.9M shares8 | 14.1M shares9 | 15.0M shares4 | 17.6M shares4 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -$1.2M5 | -$465.8K6 | -$5.7M7 | -$7.6M8 | -$3.9M9 | -$2.4M4 | -$1.5M4 |
| Capital spending | $06 | $541.2K7 | $3.2M8 | $162.9K9 | $243.8K4 | $65.3K4 | |
| Free cash flow | -$465.8K | -$6.3M | -$10.8M | -$4.1M | -$2.6M | -$1.6M | |
| Cash from investing | $522.5K9 | -$197.0K4 | -$65.3K4 | ||||
| Cash from financing | $3.3M9 | $2.6M4 | $1.7M4 |
Compare PANACEA LIFE SCIENCES HOLDINGS, INC. with another company
Leadership
Who has led PANACEA LIFE SCIENCES HOLDINGS, INC., and when. Pick a name to see everywhere that person has worked.
Chief financial officer
Chief operating officer
- Chief executive officerLeslie Buttorff Jul 2, 2021 to Sep 20, 202313
- Chief executive officerEmiliano Angel Aloi Oct 7, 2019 to Oct 7, 201914
- Chief executive officerPhilip J. Young Aug 18, 2017 to Sep 13, 201815
- PresidentEmiliano Angel Aloi Apr 23, 2019 to Oct 7, 201916
- PresidentPhilip J. Young Aug 18, 2017 to Sep 13, 201815
- Chief financial officerKen Puzder Feb 6, 2020 to Feb 6, 202017
- Chief financial officerKelley A. Wendt Aug 18, 2017 to Aug 18, 201718
- Chief operating officerAlvaro Daniel Alberttis Feb 2, 2021 to Feb 2, 202119
Board members and other officers (18)
- CONTROLLER & PRIN ACTNG OFCRNathan Joel Berman Jul 6, 2021 to Jul 12, 202120
- Chief Growth OfficerChesne Derek Du Feb 21, 2020 to Feb 21, 202021
- Chief Strategy OfficerAndrew L. Johnson Apr 9, 2019 to Feb 2, 202122
- CHIEF FIN OFFICER AND TREASKelley A. Wendt Mar 30, 2018 to Sep 13, 201823
- PRES AND CHIEF EXEC OFFICERPhilip J. Young Mar 30, 2018 to Mar 30, 201824
- Chief Business OfficerJames R. Erickson Aug 18, 2017 to Sep 13, 201825
- Board memberLawrence Wert Feb 11, 2021 to Aug 15, 202226
- Board memberLeslie Buttorff Jul 2, 2021 to Sep 20, 202313
- Board memberJanice Nerger Oct 26, 2021 to Oct 26, 202127
- Board memberAlvaro Daniel Alberttis Jan 27, 2020 to Feb 2, 202128
- Board memberJeffrey M. Thompson Jan 17, 2019 to Nov 22, 201929
- Board memberKevin James Esval Jan 17, 2019 to Nov 22, 201930
- Board memberKen Puzder Jan 23, 2019 to Feb 6, 202031
- Board memberJohn C. Price Feb 13, 2019 to Nov 22, 201932
- Board memberSteven A. Schwartz Jul 29, 2019 to Nov 12, 201933
- Board memberVladislav Yampolsky Jul 29, 2019 to Dec 13, 201934
- Board memberKrassen Dimitrov Aug 18, 2017 to Aug 18, 201735
- Board memberPhilip J. Young Aug 18, 2017 to Sep 13, 201815
Former names
Timeline
Filings
71 filings to the SEC since October 2021: 6 annual reports, 12 quarterly reports, 23 major events, 16 insider forms, 2 large holders, 12 other. The latest 20:
- May 9, 2025SEC STAFF ACTION EDGAR
- Jul 16, 202415-12G EDGAR
- Jun 11, 20241-A EDGAR
- May 16, 20248-K EDGAR
- May 7, 20248-K EDGAR
- May 6, 202410-Q EDGAR
- Apr 1, 202410-K EDGAR
- Mar 7, 20248-K EDGAR
- Feb 5, 20248-K EDGAR
- Dec 8, 20238-K/A EDGAR
- Nov 14, 202310-Q EDGAR
- Oct 5, 20238-K EDGAR
- Oct 2, 20238-K EDGAR
- Sep 20, 20234 EDGAR
- Aug 15, 202310-Q EDGAR
- Aug 15, 2023NT 10-Q EDGAR
- Jul 10, 20238-K EDGAR
- Jun 23, 2023SC 13D EDGAR
- Jun 12, 20234 EDGAR
- Jun 2, 20238-K EDGAR
The 71 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
50 open-market trades by officers, directors and large owners since October 2021: 50 buys and 0 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 18, 2023 | Buttorff LeslieCEO | Buy | 20,000 | $0.24 | $4.8K | Form 4 |
| Jun 9, 2023 | Buttorff LeslieCEO | Buy | 3,000 | $0.43 | $1.3K | Form 4 |
| May 23, 2023 | Buttorff LeslieCEO | Buy | 500 | $0.50 | $250 | Form 4 |
| May 19, 2023 | Buttorff LeslieCEO | Buy | 6,000 | $0.51 | $3.1K | Form 4 |
| May 9, 2023 | Buttorff LeslieCEO | Buy | 2,300 | $0.38 | $874 | Form 4 |
| May 8, 2023 | Buttorff LeslieCEO | Buy | 1,500 | $0.43 | $645 | Form 4 |
| May 5, 2023 | Buttorff LeslieCEO | Buy | 11,500 | $0.49 | $5.6K | Form 4 |
| Apr 26, 2023 | Buttorff LeslieCEO | Buy | 5,500 | $0.40 | $2.2K | Form 4 |
| Apr 25, 2023 | Buttorff LeslieCEO | Buy | 4,500 | $0.37 | $1.6K | Form 4 |
| Apr 5, 2023 | Buttorff LeslieCEO | Buy | 2,500 | $0.33 | $825 | Form 4 |
| Apr 4, 2023 | Buttorff LeslieCEO | Buy | 3,200 | $0.35 | $1.1K | Form 4 |
| Apr 3, 2023 | Buttorff LeslieCEO | Buy | 1,000 | $0.36 | $360 | Form 4 |
| Feb 27, 2023 | Buttorff LeslieCEO | Buy | 3,000 | $0.18 | $530 | Form 4 |
| Feb 26, 2023 | Buttorff LeslieCEO | Buy | 1,000 | $0.19 | $190 | Form 4 |
| Dec 1, 2022 | Buttorff LeslieCEO | Buy | 1,000 | $0.10 | $100 | Form 4 |
| Nov 29, 2022 | Buttorff LeslieCEO | Buy | 2,000 | $0.13 | $260 | Form 4 |
| Nov 23, 2022 | Buttorff LeslieCEO | Buy | 3,000 | $0.10 | $300 | Form 4 |
| Sep 13, 2022 | Buttorff LeslieCEO | Buy | 1,000 | $0.10 | $100 | Form 4 |
| Aug 26, 2022 | Buttorff LeslieCEO | Buy | 15,000 | $0.14 | $2.1K | Form 4 |
| Aug 19, 2022 | Buttorff LeslieCEO | Buy | 6,500 | $0.16 | $1.0K | Form 4 |
All 50 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Leslie ButtorffSC 13D, 1 filing Jun 23, 202336
- Harvey J. KesnerSC 13D/A, 1 filing Apr 5, 202237
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16SEC EDGAREmiliano Angel Aloi, President
- 17SEC EDGARKen Puzder, Chief financial officer
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26SEC EDGARLawrence Wert, Board member
- 27SEC EDGARJanice Nerger, Board member
- 28
- 29SEC EDGARJeffrey M. Thompson, Board member
- 30SEC EDGARKevin James Esval, Board member
- 31SEC EDGARKen Puzder, Board member
- 32SEC EDGARJohn C. Price, Board member
- 33SEC EDGARSteven A. Schwartz, Board member
- 34SEC EDGARVladislav Yampolsky, Board member
- 35SEC EDGARKrassen Dimitrov, Board member
- 36
- 37